The study identifies Florida spot keratopathy (FSK) as a relatively benign eye condition affecting dogs and cats, characterized by white spots on the cornea. While Florida spot keratopathy (FSK) has ...

A new study from the Koret School of Veterinary Medicine at Hebrew University has brought new insights into Florida spot keratopathy ... round spots on the cornea—the clear front surface ...

Figure 1: Florida spot keratopathy in four dogs. (A) A 9-year-old mixed breed with five paracentral lesions. (B) A 7-year-old Labrador retriever with one dorsal lesion. (C) An 8-year-old mixed ...

The study identifies Florida spot keratopathy (FSK) as a relatively benign eye condition affecting dogs and cats, characterized by white spots on the cornea. While Florida spot keratopathy (FSK) has ...

With significant advancement in medical science and surgical techniques, corneal transplant surgeries are now increasingly effective at restoring vision in patients with corneal diseases. In the last ...

bhvi.org; Dr Xun Xu; drxuxun{at}sjtu.edu.cn Purpose To develop age-specific and gender-specific reference percentile charts for axial length (AL) and AL/corneal radius of curvature (AL/CR) and, to use ...

Bullous Pemphigoid Market Outlook 2025-2035: The 7 major Bullous Pemphigoid market reached a value of USD 287.1 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1,618.1 ...

2025 could be a breakout year for the Duchenne muscular dystrophy space. Although several therapies have entered the market in recent years, there is still considerable unmet need for the 15,000 ...

Corneal graft rejection is a severe complication that can follow penetrating keratoplasty (PKP), possibly leading to severe endothelial cell loss and corneal decompensation. [1,2] Risk factors for ...

Vyznova a human corneal endothelial cell therapy. It is formulated as solution for intracameral route of administration. Vyznova is indicated for the treatment of bullous keratopathy of the cornea. AE ...

There is a simple discount patient access scheme for vamorolone. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...